Home » Topics » Regulatory » Patents

Patents
RSS

Selective thrombin inhibitors described by Merck scientists

May 20, 1998

New treatments for Alzheimer's disease in the pipeline at Schering-Plough

May 20, 1998

Chiroscience prepares new peptidyl inhibitors of MMPs and TNF production

May 20, 1998

New PDE IV inhibitors from Euroceltique

May 19, 1998

IL-8 receptor antagonists described by SKB

May 19, 1998

Neuroprotective heterocyclic compounds developed at Cambridge NeuroScience

May 19, 1998

Oral antiinflammatory/analgesic compounds with reduced ulcerogenic potential

May 19, 1998

Helopharm describes improved class III antiarrhythmic agents

May 19, 1998

Antifungal agents disclosed by Nippon Soda

May 15, 1998

Novel isoquinolines prepared at Snow Brand Milk Products inhibit neuronal cell death

May 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...